Report: Amgen ups offer for Onyx by $10 per share
August 07, 2013 at 14:01 PM EDT
Amgen Inc. upped its offer for Onyx Pharmaceuticals Inc. by $10 per share, reportedly the highest bid so far for the South San Francisco cancer drug developer, according to Bloomberg...
